PULMONARY HYPERTENSION
Clinical trials for PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled treprostinil safety trial for PH-COPD ends early
Disease control TerminatedThis study looked at the long-term safety of an inhaled drug called treprostinil in people who have both pulmonary hypertension (high blood pressure in the lungs) and COPD. It included 41 adults who had already completed a previous study. The trial was terminated early, and the m…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Heart failure drug trial ends early – only 4 patients enrolled
Disease control TerminatedThis was a very early (Phase 1) study testing a drug called HS135 in obese patients who have both pulmonary hypertension and a type of heart failure called HFpEF. The trial was terminated after enrolling only 4 people, so we have no useful information on whether HS135 is safe or …
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated Jun 26, 2026 14:09 UTC
-
Xenon MRI breathes new life into lung disease detection
Diagnosis TerminatedThis study explored whether a special type of MRI using inhaled xenon gas could detect changes in the small blood vessels of the lungs in people with pulmonary hypertension. The goal was to see if this imaging method could track disease progression or response to treatment. Howev…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE2 • Sponsor: Bastiaan Driehuys • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC